Instituto de Investigación Biomédica de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

    Biomedicine and Pharmacotherapy, Vol. 144